EU says Moderna to fill immunization gap by March 2021 Kumar Jeetendra | February 16, 2021 The European Commission says it anticipates Moderna to make up a shortfall in deliveries of its COVID-19 vaccine by next month. EU Commission spokeswoman Vivian Loonella told colleagues that Moderna told EU government about delays in vaccine deliveries for this month, but that”it’s likely” that the US company”will be caught up in March.” Spanish media …
Strides Pharma gets USFDA endorsement for Prednisone tablets Kumar Jeetendra | February 13, 2021 New Delhi: Drug company Strides Pharma Science on Friday said its subsidiary, Strides Pharma International Pte Ltd, has received approval from the US health regulator for Prednisone pills , prescribed for a variety of conditions, such as allergies, respiratory disease and arthritis. Strides Pharma Global Pte Limited, Singapore, has obtained approval for Prednisone tablets USP …
Oxford University to test COVID-19 vaccine reaction among kids for first time Kumar Jeetendra | February 13, 2021 The University of Oxford has established a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday. Approximately 300 volunteers will be registered and first inoculations are expected this month, Oxford said. The two-dose Oxford/AstraZeneca vaccine was …
Moderna to supply COVID-19 immunization to Taiwan and Colombia Kumar Jeetendra | February 10, 2021 US drugmaker Moderna Inc will supply its COVID-19 vaccine into the authorities of Taiwan and Colombia, the company said, providing five million and 10 million doses respectively. Moderna’s COVID-19 vaccine isn’t yet approved for use in Taiwan or Colombia and the company’s statement said it will work with regulators to pursue necessary approvals prior to …
India backs AstraZeneca shot in spite of South Africa halt Kumar Jeetendra | February 9, 2021 India said on Tuesday said it had no concerns over the effectiveness of the AstraZeneca COVID-19 vaccine despite South Africa putting it on hold, and ordered 10 million more doses of this shot for its huge immunisation campaign. South Africa delayed use of the vaccine after investigators found it provided minimal protection against mild-to-moderate COVID-19 …
India says Johnson and Johnson keen on making COVID-19 vaccine in country Kumar Jeetendra | February 9, 2021 Johnson & Johnson is interested in manufacturing its COVID-19 vaccine in India, a government official told a news conference on Tuesday. India also currently does not have any concern over the efficacy of the AstraZeneca vaccine that is being used in the nation’s massive inoculation campaign, Vinod Kumar Paul said.
Alembic Pharma gets five perceptions from USFDA for Gujarat office Kumar Jeetendra | February 8, 2021 Alembic Pharmaceuticals on Monday said the US health regulator has made five observations after inspection at its center at Karkhadi, Gujarat. “The United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals” New Injectable Facility (F-3) located at Karkhadi from January 29-February 5, 2021. This was a scheduled inspection and at …
Revelation may decrease the ecological effect of chemical manufacturing Kumar Jeetendra | February 7, 2021 Chemical manufacturers frequently use toxic solvents such as alcohols and benzene to make products such as pharmaceuticals and plastics. Researchers are analyzing a previously overlooked and misunderstood phenomenon in the chemical reactions used to make these products. Combining metal and ore nanoparticles hastens many chemical reactions and helps maximize yield and profit margins for the …
Oxford/AstraZeneca COVID shot less viable against South African variant: Study Kumar Jeetendra | February 7, 2021 British drugmaker AstraZeneca said on Saturday its vaccine developed by the University of Oxford seemed to offer only limited protection against mild disease caused by the South African version of COVID-19, based on early data from a trial. The study from South Africa’s University of the Witwatersrand and Oxford University revealed the vaccine had significantly …
Business certainty improves with rollout of vaccines: NCAER Kumar Jeetendra | February 7, 2021 The Business Confidence Index (BCI) developed by the Delhi-based economic think tank NCAER rose 29.6 per cent between third and second quarter of the current financial year on the back of rollout of COVID-19 vaccines in various countries, such as India. The proportion of respondents anticipating that”overall economic conditions will improve in the next six …
Oxford says COVID-19 immunization with AstraZeneca neutralizes UK variant Kumar Jeetendra | February 6, 2021 AstraZeneca and Oxford University’s COVID-19 vaccine has similar efficacy against the British coronavirus version as it does to the previously circulating variants, the university said on Friday. The version, first identified in Kent, southern England, is more readily transmissible, prompting many countries to limit travel to Britain. It also led to a spike in infections …
Johnson and Johnson files COVID-19 immunization application with US FDA Kumar Jeetendra | February 5, 2021 Johnson & Johnson said it has asked US health regulators to authorize its single-dose COVID-19 vaccine for emergency use, and it’ll apply to European authorities in coming weeks. The drugmaker’s application to the U.S. Food and Drug Administration (FDA) follows its Jan. 29 report where it said the vaccine had a 66% rate of preventing …
